Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.

Guidance development process

How we develop NICE diagnostics guidance

This guidance replaces NICE's diagnostics guidance on quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30), and partially updates the recommendations on colorectal cancer in NICE’s guideline on suspected cancer: recognition and referral.

  • National Institute for Health and Care Excellence (NICE)